How Oliveto was paid
$2.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Joseph OlivetoChief Executive Officer & President | $649,641 | $538,128 | $651,492 | $250,112 | $31,631 | $2,121,015 |
| David BharuchaChief Medical Officer | $504,185 | $162,408 | $197,638 | $141,172 | $19,060 | $1,024,463 |
| Amit HasijaChief Financial Officer and Executive Vice President of Corporate Development | $472,770 | $162,408 | $197,638 | $132,376 | $26,714 | $991,905 |
What changed and why
- $2.1MJoseph Oliveto received a total compensation of $2,121,015 for fiscal year 2025, an increase from the prior year.
- $650KSalary for the CEO increased to $649,641 from $601,520 in the previous year.
- Equity incentives for named executive officers in 2025 consisted of performance-based stock options and performance stock units.
- 55%Target annual bonus for the CEO was increased to 55% of base salary for 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.